InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+130.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Baker G Leonard Jr, Director. Officer active across 2 companies, notably Corcept Therapeutics INC. In total, 7 reports have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €3.1m. History available since 18 May 2021. The latest transaction was disclosed on 17 March 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Baker G Leonard Jr
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
75,782 shares@ US$33.002267.5% of flowCommon StockSEC:0001201715-26-000007:0
Canonical exit: 15 Jun 2026 (T+90)
30,000 shares@ US$5.864.4% of flowCommon StockSEC:0001201715-26-000005:0
00Common StockSEC:0001201715-26-000003:0
00Common StockSEC:0001225208-25-000061:0
00Common StockSEC:0001225208-23-007580:0
50,000 shares@ US$21.5326.3% of flowCommon StockSEC:0001225208-21-009444:0
Canonical exit: 9 Sept 2021 (T+90)
30,000 shares@ US$6.554.8% of flowCommon StockSEC:0001225208-21-008372:0
7 of 7 declarations
About Baker G Leonard Jr
Leonard G. Baker Jr. is a Director at CORCEPT THERAPEUTICS INC. As a board member, he contributes to the governance of the company and strategic decision-making. Leonard brings valuable expertise in the biotechnology field, helping CORCEPT navigate a complex environment and focus on innovation. His commitment to excellence is an asset to the company.
